Financial Advantage’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-240
Closed -$6K 238
2013
Q3
$6K Hold
240
0.01% 160
2013
Q2
$6K Buy
+240
New +$6K 0.01% 165